The present invention relates to antibodies targeting the membrane bound IgM (mIgM) of the B-cell receptor complex found in B-cell lymphomas and leukemias and uses thereof. Another aspect of the present invention is the use of anti-B-Cell mIgM antibodies in the treatment of Be-cell malignancies, including B-cell lymphomas and leukemias.
申请公布号
WO2015084736(A2)
申请公布日期
2015.06.11
申请号
WO2014US67957
申请日期
2014.12.01
申请人
WELT BIO-MOLECULAR PHARMACEUTICAL, LLC;WELT, SYDNEY
发明人
WELT, SYDNEY;KOSTYAL, DAVID;WELT, RACHEL, S.;RAYMOND, VIRGINIA;WELT, JONATHAN, A.